Freshpet CEO Billy Cyr joins Vital Farms board of directors

AUSTIN - Vital Farms (NASDAQ:VITL), a $1.76 billion market cap company currently trading at $39.54, announced the appointment of William B. "Billy" Cyr to its board of directors effective July 1, 2025. Cyr, who currently serves as Chief Executive Officer of Freshpet, Inc., brings over 40 years of consumer packaged goods experience to the board. According to InvestingPro data, Vital Farms maintains excellent financial health with a strong balance sheet and robust growth metrics.

Cyr has led Freshpet since September 2016 and previously served as President and CEO of Sunny Delight Beverages Co. His career also includes 19 years at Procter & Gamble, where he rose to Vice President and General Manager of the North American Juice Business and Global Nutritional Beverages.

"I have long admired Vital Farms as a mission-driven company and I am pleased to join the board," Cyr said in a press release statement.

Cyr will serve on the board’s audit committee, replacing Karl Khoury, who will move to the nominating and governance committee. Khoury replaces Denny Marie Post, who continues as the board’s Lead Independent Director.

The new appointment expands Vital Farms’ board to nine members. Cyr joins the class of directors that will stand for election at the company’s 2027 annual meeting of stockholders.

Vital Farms, a Certified B Corporation founded in 2007, produces pasture-raised eggs and other ethically produced foods. The company works with over 450 family farms and sells its products in approximately 26,000 stores nationwide. With revenue growth of 24% in the last twelve months and a healthy current ratio of 3.35, the company demonstrates strong operational execution. InvestingPro analysis indicates the stock is trading at premium multiples, suggesting investors are pricing in continued growth expectations. For detailed valuation insights and 12 additional ProTips, visit InvestingPro.

In other recent news, Vital Farms reported its first-quarter 2025 earnings, revealing an earnings per share (EPS) of $0.37, which exceeded analyst expectations of $0.28. However, the company’s revenue of $162.6 million fell slightly short of projections, contributing to a mixed market reaction. Despite the revenue miss, Vital Farms maintains a strong cash position with $161.3 million and no debt. Analysts from DA Davidson and Telsey Advisory Group have provided their perspectives on the company’s performance. DA Davidson maintained a Buy rating with a price target increase to $44, citing Vital Farms’ strategic pricing and tariff management. Telsey Advisory Group, while lowering its price target to $46, continues to rate the stock as Outperform, acknowledging the company’s adjusted EBITDA beat and full-year guidance. The analysts highlighted the company’s proactive supply and capacity expansion efforts as key factors supporting its growth prospects. These developments come as Vital Farms navigates market challenges, including supply constraints and tariff impacts.

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.